Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500484 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
A Early Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT03500484 is a Early Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 13 participants.
The verdict
NCT03500484, a Early Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.
Interventions
- DRUG Liraglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-06-06 |
| Est. Completion | 2020-06-25 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03500484
The ClinicalTrials.gov registry entry for NCT03500484 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liraglutide is the first listed.
NCT03500484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03500484 about?
NCT03500484 is a clinical study titled "Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.". To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.
What is the current status of trial NCT03500484?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2018-06-06. Estimated completion is 2020-06-25.
What interventions are being tested in trial NCT03500484?
The interventions under investigation include: Liraglutide (DRUG).
Who is sponsoring clinical trial NCT03500484?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.